Andrews Ronald Asbury
- SEC CIK
- 0001299153
No open-market purchases or sales filed in the past year.
Current role at each company
- CNSY Cerenome, Inc.Directoras of Jul 1, 2026
- PRPO Precipio, Inc.Directoras of Jan 20, 2026
- IMDX Insight Molecular Diagnostics Inc.Former CEOas of Dec 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Andrews Ronald Asbury as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMDX Insight Molecular Diagnostics Inc.
Former CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Andrews Ronald AsburyPresident & CEO | PPurchaseCommon Stock, no par value | +40.0K | $0.96 | +$38.4K | +13.6%333.2K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Andrews Ronald AsburyChief Executive Officer | PPurchaseCommon Stock, no par value | +50.0K | $1.28 | +$64.0K | +20.6%293.2K after |